Risk factor
Very high price volatility
Profitability factor
Strong growth
About
Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging...
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers.
Target Price
The average target price of TEM is 77 and suggests 55% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell